| Internet-Based Technologies Impact on Clinical Trials To Be Addressed by Merck, Pharmacia, and Aventis at CRO-Pharma Partnerships Conference in Washington, DC, on October 10-11 | |
|
WASHINGTON, Aug. 30 /PRNewswire/
-- "Sponsor - CRO Clinical Partnerships Meet the Future," a
high-level executive meeting organized to analyze the new market forces
driving industry profitability and cost containment, will address as a
conference highlight discussion of the impact of Internet-based efforts in
clinical research areas, announces Strategic Research Institute. Speakers
from pharma giants Merck, Pharmacia Corporation and Aventis will be
featured on this topic. The conference will take place in Alexandria, VA
on October 10-11 of this year.
The pharma speakers will discuss on their panels the huge impact of
web-based technologies in clinical trials, such as: The conference is distinguished by the high-level executive
participation from the pharmaceutical, CRO, regulatory, legal, site,
internet, financial, academic, and other members of the clinical research
community who will convene for two days to discuss the future of the
industry. The agenda is detailed below. To register or request additional information, contact Glenn Pascual at
gpascual@srinstitute.com or 212-967-0095, x245. For sponsorship and exhibition opportunities, contact Mark Alexay at
malexay@hotmail.com or 212-967-0095, x251. AGENDA Panel Discussion: A Look at Market Forces Shaping the Clinical
Trials Industry This session will focus on five primary forces that are impacting the
clinical trials industry today. The issues include: 1. Mergers and Pressures on CROs 2. Regulatory Requirements (impact on IRBs) 3. Emerging study conduct providers (hospitals, independent research
centers, large networks) 4. Productivity performance pressures 5. Technology trends Moderator: Joan A. Kroll, Product & Marketing Manager, CENTERWATCH Panelists: Michael A. Martorelli, CFA, Managing Director, Research, PENNSYLVANIA
MERCHANT GROUP Gary Chadwick, PharmD, MPH, Executive Director, UNIVERSITY OF
ROCHESTER Mark Di Ianni, Executive Vice President, SCIREX, INC. Samuel T. Barnett, Partner, PRICE WATERHOUSE COOPERS Jim Patricelli, Director, DEUTSCHE BANC ALEX. BROWN Panel Discussion: Industry Consolidation & Deal-Making:
Impact of Mergers & Acquisitions on Service Providers -- Solutions
& Concerns Michael A. Martorelli, CFA, Managing Director, Research, PENNSYLVANIA
MERCHANT GROUP Bruce Kreter, Vice President, Clinical Research, KENDLE INTERNATIONAL Mark Harvill, Director, Business Development, STATPROBE Panel Discussion: What Is the Future Role for Niche Providers:
Can Too Many Cooks Spoil the Broth? Moderator: Kathy Cox, Ph.D., President, PHARMASEEK, INC. Panelists: Christopher T. Speh, MA, MBA, President, RESOURCE SOLUTIONS, INC. Kathleen Harper, FUJISAWA Ann Devine, OMNICARE Panel Discussion: Global Outsourcing Strategies: The Evolution
of Strategic Alliances Maria Malae Dotson, Vice President, Global Clinical Operations,
QUINTILES, INC. (invited) Jack Vandeventer, Director, Global Sourcing, ELI LILLY & COMPANY Gene Richardson, Director, Global Strategic Alliances, RW JOHNSON,
PRI Panel Discussion: Current Trends in the Evolving Relationships
Between Service Providers Moderator: Susan Callery-D'Amico, Ph.D., Senior Director, Global Clinical
Operations, RW JOHNSON PRI Panelists: Bob Aromondo, Director, COVANCE, INC. Paul Ottaviano, MS, MBA, Executive VP, World Wide Operations and COO,
CLINTRIALS RESEARCH INC. Leslie Cate, Vice President Clinical Operations, nTOUCH RESEARCH
CORPORATION Frank Willis, J.D., Executive Vice President, LYNN HEALTH SCIENCE
INSTITUTE Panel Discussion: The Evolving Role of Scientific, Regulatory,
and Legal Consulting in Catalyzing Partnerships Among Developers,
Investors, and CROs Moderator: Gilbert Alexander Fleming, M.D., Senior VP, Global Regulatory
Affairs, WORLDWIDE CLINICAL TRIALS, INC./INGENIX INTERNATIONAL, (Former
Member of the FDA) Panelists: Frank Sasinowski, Esq., Counsel, HYMAN, PHELPS, & MCNAMARA David Lepay, M.D., Recently appointed Chief Clinical Advisor, Office
of the Commissioner, FDA W. Leigh Thompson Jr. MD, PhD, Former Chief Scientific Officer, ELI
LILLY & COMPANY Alexander Walker, M.D., recently retired chairman, Dept of
Epidemiology, HARVARD SCHOOL OF PUBLIC HEALTH (and VP, EPIDEMIOLOGY
RESEARCH INSTITUTE) Alan Moses, M.D., Chief Medical Officer, Joslin Clinic, HARVARD
MEDICAL SCHOOL Ronald Waife, President, WAIFE & ASSOCIATES Panel Discussion: Risk Sharing in the Partnership or Is the
Partnership at Risk? Strategies for the Future in Sponsor/Service Provider
Relationships (5 Year Forecast) Moderator: William Orr, Ph.D., President & CEO, LYNN HEALTH SCIENCE INSTITUTE Panelists: Carole Sampson- Landers, Ph.D., Executive Medical Director,
BRISTOL-MYERS SQUIBB Pat O'Connor, MRCP, Ph.D., Senior VP, Global Clinical Affairs, PPD
DEVELOPMENT Steve Rauscher, CEO, AMERICASDOCTOR.COM Frank Willis, J.D., Executive Vice President, LYNN HEALTH SCIENCE
INSTITUTE Teresa Stem, Ph.D., President, TQM RESEARCH Panel Discussion: Evolving Issues in Patient Recruitment Today:
Trends and Solutions for Tomorrow Moderator: Diana Anderson, Ph.D., President and CEO, RHEUMATOLOGY RESEARCH
INTERNATIONAL, INC. Panelists: Lisa Felkins, RN, BSN, Senior Project Manager, Product Experience,
GENENTECH, INC. (invited) Susan Krivacic, Ph.D., Senior VP of Marketing & Business
Development, CLINICOR, INC. Noah Berkowitz, M.D., Ph.D., Vice President Information Services,
IMPATH John Ogle, Former Chief Scientific Officer, QUINTILES AMERICA
(invited) Panel Discussion: A Look into the Future of Web-Based Systems:
The Impact of New Technologies on Service Providers and The Transformation
into a Virtual Document Process Moderator: Ronald Waife, Ph.D., President, WAIFE & ASSOCIATES, INC. Panelists: Gregory Holmes, PharmD, Executive Vice President, Clinical
Operations, SFBC INTERNATIONAL, INC. Daniel Fakouhi, M.D., Senior Director, Clinical Trial Affairs,
PHARMACIA CORPORATION Adrian Otte, Ph.D., Chief Operating Officer, INNOVATIVE CLINICAL
SOLUTIONS, LTD Art Shedden, MD, MBA, Director, Clinical Research, MERCK &
COMPANY SOURCE: Strategic Research Institute ST: District of Columbia, Virginia |
|
This press release may not be redistributed without prior written approval by PR Newswire. |
|
| Posted August 30, 2000. |
Go to: